State of the ART (antiretroviral therapy): Long-acting HIV-1 therapeutics

SM Ravichandran, WM McFadden… - Global Health & …, 2024 - jstage.jst.go.jp
Human immunodeficiency virus (HIV) impacts millions of individuals worldwide, and well
over 2/3 of those living with HIV are accessing antiviral therapies that are successfully …

Breakthrough Acute HIV Infections among Pre-Exposure Prophylaxis Users with High Adherence: A Narrative Review

D Moschese, S Lazzarin, ML Colombo, F Caruso… - Viruses, 2024 - mdpi.com
Pre-exposure prophylaxis (PrEP) is a pivotal intervention among HIV prevention strategies.
We aimed to narratively revise the topic of HIV acute infection in the setting of PrEP …

HIV preexposure prophylaxis in adolescents and young adults: an update

C Camfield, YN Evans… - Current Opinion in …, 2024 - journals.lww.com
Adolescents and young adults have many options when it comes to HIV prevention, but
barriers persist in terms of uptake and adherence to PrEP and retention in care. Technology …

Exploring the modulatory effects of aspirin on vaginal immunity

M Taverner - 2024 - mspace.lib.umanitoba.ca
Introduction: Human cohort studies associate bacterial vaginosis (BV) with adverse
reproductive health outcomes such as genital inflammation and increased HIV acquisition …

AVANÇOS NA PREVENÇÃO DO HIV: PROGRESSOS E DESAFIOS NA IMPLANTAÇÃO DA PROFILAXIA PRÉ-EXPOSIÇÃO

BÉF dos Santos, JGB Miranda… - Revista …, 2024 - ojs.revistacontemporanea.com
Introdução: A prevenção do HIV constitui um pilar fundamental no combate à epidemia
global de AIDS. Recentemente, a introdução da Profilaxia Pré-Exposição (PrEP) …

[引用][C] PrEP: Profilassi Pre esposizione. Descrizione e Analisi di una Coorte Ligure.

F Rismondo - 2024 - Università degli studi di Genova